Korea Continuous Glucose Monitoring Devices Market Expected to Reach @marketSize @valueUnit by 2033

Key Insights

The Korea Continuous Glucose Monitoring (CGM) Devices market is experiencing robust growth, projected to reach \$84.24 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 9.40% from 2025 to 2033. This expansion is driven by several key factors. Rising prevalence of diabetes, particularly in urban centers like Seoul, Busan, and Incheon, fuels demand for advanced glucose management solutions. Increasing awareness of the benefits of CGM devices—improved diabetes control, reduced hypoglycemic events, and enhanced patient quality of life—is a significant driver. Technological advancements, leading to smaller, more user-friendly devices with longer battery life and improved accuracy, further stimulate market growth. The market segmentation reveals a strong focus on durable components (receivers and transmitters) alongside sensors, indicating a preference for comprehensive CGM systems. The presence of established international players like Dexcom, Eversense, Medtronic, Abbott, and Ascensia highlights the market's maturity and potential for further investment and innovation. However, factors like high device costs and limited insurance coverage could potentially restrain market expansion. Future growth will likely hinge on the government's initiatives to improve healthcare accessibility and affordability, alongside continued technological advancements and public health awareness campaigns.

The competitive landscape is characterized by a mix of global and potentially local players. While the data focuses on the presence of major international companies, the "Other Provinces" segment suggests opportunities for regional players or smaller companies specializing in particular aspects of CGM technology. The historical period (2019-2024) likely shows a growth trajectory mirroring the projected CAGR, suggesting a consistent upward trend. Further research could focus on specific provincial market penetration rates and the evolving dynamics within the component segments (sensors versus durables). Understanding the pricing strategies of key players and the impact of reimbursement policies will be crucial for gaining a holistic view of this rapidly expanding market.

Korea Continuous Glucose Monitoring (CGM) Devices Market: A Comprehensive Report (2019-2033)

This comprehensive report provides an in-depth analysis of the Korea Continuous Glucose Monitoring (CGM) Devices market, offering actionable insights for stakeholders across the industry. We cover market dynamics, industry trends, key segments, leading players, and future growth opportunities, utilizing data from the historical period (2019-2024), base year (2025), and forecast period (2025-2033). The market is segmented by provinces (Seoul, Busan, Daegu Metropolitan City, Incheon Metropolitan City, Gwangju, and Other Provinces) and components (Sensors, Durables – Receivers and Transmitters). Key players analyzed include Dexcom Inc, Eversense, Medtronic PLC, Abbott Diabetes Care Inc, and Ascensia. The report projects a market value of xx Million by 2033.

Korea Continuous Glucose Monitoring Devices Market Concentration & Dynamics

The Korean CGM market exhibits a moderately concentrated landscape, with a few major players holding significant market share. However, the market is dynamic, driven by continuous innovation and regulatory changes. The innovation ecosystem is active, with ongoing research and development focused on improving CGM accuracy, usability, and integration with insulin delivery systems. The regulatory framework, while generally supportive of medical device innovation, presents certain hurdles for market entry and product approvals. Substitute products, such as intermittent self-monitoring of blood glucose (SMBG), still hold a place in the market, though the increasing preference for continuous monitoring is driving market growth. End-user trends show a growing preference for smaller, more comfortable, and user-friendly devices with advanced features like automated insulin delivery integration. The market has witnessed several M&A activities in recent years, reflecting the strategic importance of this sector. For instance, Medtronic PLC's acquisition of EOFlow Co. Ltd. in 2023 underscores the ongoing consolidation and expansion within the market.

• Market Concentration: The top 5 players account for approximately xx% of the market share in 2025.
• M&A Activity: A total of xx M&A deals were recorded during the study period (2019-2024).
• Regulatory Landscape: Stringent regulatory approvals create a barrier to entry, but also ensure product safety and quality.
• Innovation Ecosystem: Significant R&D investments are driving advancements in CGM technology.

Korea Continuous Glucose Monitoring Devices Market Industry Insights & Trends

The Korean CGM market is experiencing robust growth, driven by increasing diabetes prevalence, rising healthcare expenditure, and growing awareness of the benefits of continuous glucose monitoring. The market size is estimated at xx Million in 2025, with a projected Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033). Technological disruptions, particularly advancements in sensor technology and data analytics, are further fueling market expansion. Consumer behavior is shifting towards a preference for non-invasive and user-friendly CGM systems, increasing demand for improved accuracy and integration with other diabetes management tools. The rising adoption of telehealth and remote patient monitoring also contributes to the growth of the CGM market. Price sensitivity remains a factor, as seen in the 10% price increase announced by Adela for Abbott Freestyle Libre in January 2023 due to inflation. Despite this, the convenience and improved health outcomes associated with CGM are expected to offset price concerns for a significant portion of the market.

Key Markets & Segments Leading Korea Continuous Glucose Monitoring Devices Market

The Seoul region holds the largest market share among the provinces, driven by higher diabetes prevalence, greater healthcare infrastructure, and a higher concentration of medical professionals. Busan, Daegu Metropolitan City, and Incheon Metropolitan City also contribute significantly to the market. Within the components segment, sensors dominate, accounting for xx% of the market value in 2025. However, the durable segment (receivers and transmitters) is expected to see strong growth due to technological improvements and the increasing demand for advanced features.

• Drivers for Seoul's dominance:

  • High diabetes prevalence.
  • Well-developed healthcare infrastructure.
  • High concentration of specialized medical facilities.
  • Higher disposable income.

• Drivers for growth in the Sensor Segment:

  • Technological advancements leading to smaller, more accurate sensors.
  • Increased demand for continuous monitoring.

• Drivers for growth in the Durables Segment:

  • Enhanced functionalities of receivers and transmitters.
  • Growing demand for integrated insulin delivery systems.

Korea Continuous Glucose Monitoring Devices Market Product Developments

Recent product innovations focus on improving sensor accuracy, reducing insertion discomfort, extending sensor lifespan, and enhancing data integration with other diabetes management tools. These advancements are providing users with more convenient and effective diabetes management solutions, contributing to increased market adoption. Miniaturization and improved comfort are key differentiators in the competitive landscape. The development of systems that seamlessly integrate with insulin pumps and other connected devices represents a significant area of focus, improving the overall patient experience.

Challenges in the Korea Continuous Glucose Monitoring Devices Market Market

The Korean CGM market faces challenges including the high cost of devices, stringent regulatory approvals, potential supply chain disruptions, and the competitive pressure from established players and new entrants. The high cost of CGM systems can be a barrier to access for some patients. Furthermore, navigating regulatory approvals and maintaining a secure and efficient supply chain poses significant operational challenges. The market faces competitive pressure from both existing players and new entrants continuously developing improved technologies. These challenges, while present, are not insurmountable, and the market's overall trajectory remains strongly positive.

Forces Driving Korea Continuous Glucose Monitoring Devices Market Growth

The market's growth is primarily propelled by the rising prevalence of diabetes in Korea, increased healthcare expenditure, technological advancements leading to more user-friendly and accurate devices, and government initiatives promoting diabetes management. The expanding awareness about the advantages of continuous glucose monitoring among both patients and healthcare professionals contributes significantly to market expansion. Furthermore, growing integration with mobile health (mHealth) applications and remote patient monitoring programs is boosting market demand.

Long-Term Growth Catalysts in Korea Continuous Glucose Monitoring Devices Market

Long-term growth will be fueled by continuous innovation in sensor technology, the development of advanced algorithms for improved data analysis and predictive capabilities, and strategic partnerships between CGM manufacturers and telehealth providers. Expansion into underserved rural areas and targeted marketing campaigns for increased patient awareness will also contribute to sustained market growth. The growing adoption of hybrid closed-loop systems that integrate CGM with insulin pumps represents a significant long-term opportunity.

Emerging Opportunities in Korea Continuous Glucose Monitoring Devices Market

Emerging opportunities lie in the development of non-invasive CGM technology, personalized diabetes management solutions leveraging AI and machine learning, and the integration of CGM data with other wearable health technologies to provide a holistic view of patient health. Expansion into new patient segments, including those with type 1 and type 2 diabetes, as well as gestational diabetes, presents significant market potential. The growing interest in remote patient monitoring and telehealth offers opportunities for CGM manufacturers to collaborate with healthcare providers to improve diabetes care delivery.

Leading Players in the Korea Continuous Glucose Monitoring Devices Market Sector

• Dexcom Inc
• Eversense
• Medtronic PLC
• Abbott Diabetes Care Inc
• Ascensia

Key Milestones in Korea Continuous Glucose Monitoring Devices Market Industry

• May 2023: Medtronic PLC acquired EOFlow Co. Ltd., expanding its product portfolio and capabilities in CGM and insulin delivery systems. This acquisition is expected to significantly impact the market share and competition.
• January 2023: Adela announced a 10% price increase for Abbott Freestyle Libre in Korea due to rising raw material costs and inflation, impacting market pricing dynamics and consumer affordability.

Strategic Outlook for Korea Continuous Glucose Monitoring Devices Market Market

The future of the Korean CGM market is promising. Continuous innovation, strategic partnerships, and increasing patient awareness will drive market expansion. The integration of CGM with other diabetes management technologies and the growing adoption of telehealth will create new opportunities for growth. Focusing on personalized diabetes management solutions and addressing challenges related to cost and access will be critical for sustained market success. The market's long-term outlook is positive, with significant potential for continued growth and expansion.

Korea Continuous Glucose Monitoring Devices Market Segmentation

• 1. Component
  • 1.1. Sensors
  • 1.2. Durables (Receivers and Transmitters)
• 2. Provinces (Quantitative Analysis)
  • 2.1. Seoul
  • 2.2. Busan
  • 2.3. Daegu Metropolitan City
  • 2.4. Incheon Metropolitan City
  • 2.5. Gwangju
  • 2.6. Other Provinces

Korea Continuous Glucose Monitoring Devices Market Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific